| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Potassium Chloride | Laborate Ltd. | ?mg | 1s | Inj | per Vial | KES 40 | |
| Mode Of Action | Potassium is the main intracellular cation. Na+K+ATPase actively pumps sodium out and potassium into cells to maintain these concentration gradients. These potassium concentration gradients are necessary for the conduction of nerve impulses it the heart, brain, and skeletal muscle, and for the maintenance of normal renal function and acid-base balance. High intracellular potassium concentrations are necessary for numerous cellular metabolic processes. |
|---|---|
| Drug Indication | Treatment and prophylaxis of hypokalaemia; metabolic alkalosis; in chronic digitalis intoxication; hypokalaemic familial periodic paralysis; those on potassium-depleting drugs like thiazides and loop diuretics; hepatic cirrhosis with ascites; in chronic and secondary hyperaldosteronism; chronic diarrhoea; chronic laxative use; prolonged vomiting; long-term corticosteroid therapy; potassium losing nephropathy; Bartter's syndrome. |
| Precautions | The loss of fluid accompanied by the use of potassium supplements can cause renal toxicity; conditions that can cause delay absorption of potassium can cause or worsen GIT irritation; conditions predisposing to hyperkalaemia, such as acute metabolic acidosis, adrenal insufficiency, acute dehydration, and uncontrolled diabetes mellitus. |
| Contra-Indications | Hyperkalaemia |
| Dosage | Prophylaxis 2-3 tabs dailly, Correction 5-6 tabs dailly max 12 per day. |
| Side Effects | Hyperkalaemia; irritation of the GIT; diarrhoea; nausea; vomiting; hypersensivity to potassium |
| Drug Category | DRUGS AFFECTING NUTRITION AND METABOLISM |
| Drug Sub-Category | Other minerals and nutritional additives |